HIV is a manageable condition and people living with it and live long, healthy and productive lives. However, people living with HIV often are forced to hide their conditions (or worse, not even get tested) for fear that they will be stigmatized and discriminated against
For the first time ever, the developing world is taking a greater financial share of fighting HIV/AIDS than wealthier countries. This is the key finding of a new report from UNAIDS, which shows that in 2011, low and middle income countries contributed $8.6 billion to fighting HIV/AIDS compared to $8.2 billion from the developed world.
"The FDA Approves Truvada for PrEP" is a terribly jargon laden phrase that just might mark a turning point in the 30 year fight against HIV/AIDS. Here's what that means and why yesterday's news is so potentially significant.
The home test kit for HIV will help some people. Every tiny step forward in increasing access helps. BUT it’s not a global health breakthrough – not at this price point.
The scientific promise for the end of HIV is the brightest it’s ever been. We’re poised, medically, to bring this epidemic to its knees. Yet on World AIDS Day, the global community seems more indifferent than ever before to HIV.
How UNITAID strives to bring down the cost of expensive second line HIV/AIDS medicines.
Blogging from Cameroon this week, on a UNITAID sponsored trip to examine HIV/AIDS, Malaria and TB programs.
The HIV drug combination of tenofovir and emtricitabine appears to be highly effective at preventing the acquisition of HIV. It’s a simple one pill daily regimen, and it is available for as little as 25 cents a day.
UNAIDS just released a 30 year stock taking of the global fight against HIV/AIDS. The report, AIDS at 30: Nations at the Crossroads, is voluminous, but contains some interesting factual nuggets about recent progress against the disease.